US 8697727
N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
granted A61PA61P3/06A61P3/10
Quick answer
US patent 8697727 (N-substituted-heterocycloalkyloxybenzamide compounds and methods of use) held by Rigel Pharmaceuticals, Inc. expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P3/06, A61P3/10, A61P43/00, A61P9/00